Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Bioline Rx Ltd - ADR
Swot
Bioline Rx Ltd - ADR SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Bioline Rx Ltd - ADR has 15 Strengths, 9 Weaknesses, 1 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(15)
Weakness
(9)
Opportunity
(1)
Threats
(0)
Others
(1)
Price crossing above SMA20 today, and greater than SMA5
Relative Outperformance versus Industry over 1 Month
Stocks whose current price is 20% higher than week low, and more than previous close
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
High Volume, High Gain
Top Gainers
Stock with Low PE (PE < = 10)
RSI indicating price strength
Volume Shockers
High Volume, High Gain
Biggest Price Gainers from Open
Highest Recovery from 52 Week Low
Companies with growing costs YoY for long term projects
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Highest fall from 52 Week High
Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
Low Piotroski Score : Companies with weak financials
Book Value Per Share deteriorating for last 2 years
Recent Results: Declining Operating Profit Margin and Net Profits (YoY)
Profit to Loss Companies
Stocks Underperforming their Industry Price Change in the Quarter
Institutions increasing their shareholding
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks